Related Publications
07/18/07
CMS Proposes Changes to Its Policies Governing Off-Label Uses of Anticancer Drugs and Biologicals
02/14/07
The Anatomy of a Deal: Dissecting the Bio-Bucks, presented at the BIO CEO and Investor Conference, New York
View all publications
- Represented pharmaceutical manufacturers regarding FDA, healthcare regulation, antitrust and state regulatory requirements relating to drug pricing, distribution and promotion programs.
- Litigated market exclusivity issues for a major pharmaceutical manufacturer concerning FDA approval of a generic version of its product.
- Negotiated a multistate consent settlement and related FDA enforcement action involving the promotion of prescription drugs and provision of pharmacists’ information services.
- Successfully represented a major pharmaceutical manufacturer in switching a combination drug from prescription to over-the-counter.
Copyright © 2008 by Morgan, Lewis & Bockius LLP. All Rights Reserved.
